Doctors and their Addictions

View >

PL02-Neurobiological Signatures of Addiction Drive Novel Treatment Interventions
PL03-Has Covid-19 left an impact on our mental health?

View >

Substance use and addictions in the WHO Eastern Mediterranean Region – how to promote and protect health in the post-Covid 19 era

View >

Clinical research in the treatment of methamphetamine use disorder – where are we now and where are we going?

View >

How “Dark” is the Darknet? The expansion of crypto- markets latest trends and health risks.

View >

Are psychedelic drugs the future of addiction treatments?

View >

Gaming disorder in a pandemic reality: building resilience of care response globally.

View >

Was Human Immunodeficiency Virus a Prelude for Covid-19?

View >

Rapid harm reduction responses to the emerging pandemic in Europe

View >

What is next? Role of early career professionals in reshaping addiction medicine in the post- pandemic world

View >

Strengthening global response to substance use and addictive behaviours: recent developments and post-COVID-19 future

View >

Addiction and stress vulnerabilities: relationship to risk and relapse outcomes

View >

Opioids after surgery and trauma in Europe: Is there an opioid epidemic?

View >

Displacement, Intergenerational Trauma and Addiction

View >

Neuromodulation for substance use disorder: current situation and future direction

View >

Drug Policy and Human Rights: Do they actually support each other?

View >

Skin and soft tissue infections among people who inject drugs: reinvigorating a needed harm reduction response

View >

Alcohol & Drug Addiction: The Gain in the Brain is in the Pain

View >

The International scheduling system for narcotic drugs and psychotropic substances: Does it need an overhaul?

View >

Community based approaches to eliminating Hepatitis C virus (HCV)

View >

Rethinking Addiction: confronting stigma and harnessing the power of real stories

View >